Skip to main content
Bladder CancerCancerKidney and urinary

What this study is

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

Study details

Sponsor
Cedars-Sinai Medical Center
Conditions
Bladder Cancer
Enrolling
900 people
Starts
2016-12-30
Est. completion
2029-02
Record
View on ClinicalTrials.gov ↗